ISO/IEC 2022
Character encoding standard
| Album | |
|---|---|
| Language | |
| English title | |
| A-side | |
| B-side | |
| Released | |
| Recorded | |
| Studio | |
| Genre |
ISO/IEC 2022 is an international standard for character encoding, developed by the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC). The standard specifies a framework for encoding character sets and provides mechanisms for switching between different character sets within a single data stream.
Overview
ISO/IEC 2022 is designed to support multiple character sets, allowing for the inclusion of characters from various languages and symbol sets. It is particularly useful in environments where multiple languages are used, such as in international communication systems.
The standard defines a structure for character codes and extension techniques, enabling the use of different character sets without conflict. It includes mechanisms for designating and invoking character sets, as well as for switching between them dynamically.
Character Sets
ISO/IEC 2022 supports a wide range of character sets, including:
- ISO/IEC 646 (a 7-bit character set similar to ASCII)
- ISO/IEC 8859 (a series of 8-bit character sets for different languages)
- ISO/IEC 10646 (the Universal Character Set, which includes Unicode)
Escape Sequences
One of the key features of ISO/IEC 2022 is the use of escape sequences to switch between different character sets. An escape sequence is a series of bytes that signals a change in the character set being used. These sequences allow for the dynamic inclusion of characters from different sets within the same data stream.
Applications
ISO/IEC 2022 is used in various applications, including:
- Email systems, particularly those that need to support multiple languages
- Telecommunications systems
- Text processing software
Related Standards
ISO/IEC 2022 is related to several other standards, including:
See Also
- Character encoding
- ISO/IEC 646
- ISO/IEC 8859
- ISO/IEC 10646
- Unicode
- International Organization for Standardization
- International Electrotechnical Commission
References
This article is a standards- or measurement-related stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD